Literature DB >> 12372664

Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia.

Lorenz Leumann1, Joram Feldon, Franz X Vollenweider, Katja Ludewig.   

Abstract

BACKGROUND: Prepulse inhibition and latent inhibition are the two animal paradigms currently dominating neuropharmacological research on attentional deficits in schizophrenia. Both paradigms have been shown to have a reasonable amount of face, predictive, and construct validity, but responsiveness to typical and atypical antipsychotics differs between the two, as indicated by animal and human studies. The relationship between the paradigms in schizophrenic patients is still unclear.
METHODS: We tested prepulse inhibition and auditory latent inhibition in a sample of 33 chronic schizophrenic patients medicated either with atypical (n = 17) or typical (n = 16) antipsychotics.
RESULTS: Latent inhibition was found to be intact in both patient groups. Prepulse inhibition was intact in the group receiving atypicals, but deficient in the group receiving typicals (at 60 msec lead interval condition).
CONCLUSIONS: The direct comparison supports the hypothesis that atypical and typical antipsychotics have different effects on prepulse inhibition than on latent inhibition in schizophrenic patients; however, the results may also be explained by a greater sensitivity of the prepulse inhibition method. Because it is crucial to understand why there are considerable differences between the two paradigms and between human and animal studies, research should focus more strongly on comparative approaches.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372664     DOI: 10.1016/s0006-3223(02)01344-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  33 in total

1.  Modeling an anti-amyloid combination therapy for Alzheimer's disease.

Authors:  Vivian W Chow; Alena V Savonenko; Tatiana Melnikova; Hyunsu Kim; Donald L Price; Tong Li; Philip C Wong
Journal:  Sci Transl Med       Date:  2010-01-06       Impact factor: 17.956

2.  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition.

Authors:  Daniel Klamer; Erik Pålsson; Kim Fejgin; Jianhua Zhang; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.

Authors:  D Peleg-Raibstein; E Sydekum; H Russig; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

4.  Mutual independence of 5-HT(2) and α1 noradrenergic receptors in mediating deficits in sensorimotor gating.

Authors:  Sarah K Baisley; Katherine L Fallace; Abha K Rajbhandari; Vaishali P Bakshi
Journal:  Psychopharmacology (Berl)       Date:  2011-09-23       Impact factor: 4.530

5.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Learned irrelevance and associative learning is attenuated in individuals at risk for psychosis but not in asymptomatic first-degree relatives of schizophrenia patients: translational state markers of psychosis?

Authors:  Ariane T Orosz; Joram Feldon; Andor E Simon; Leonie M Hilti; Kerstin Gruber; Benjamin K Yee; Katja Cattapan-Ludewig
Journal:  Schizophr Bull       Date:  2010-01-15       Impact factor: 9.306

8.  Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.

Authors:  A V Savonenko; T Melnikova; F M Laird; K-A Stewart; D L Price; P C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

Review 9.  [Why do schizophrenic patients smoke?].

Authors:  K Cattapan-Ludewig; S Ludewig; E Jaquenoud Sirot; M Etzensberger; F Hasler
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

10.  Uncontrollable voices and their relationship to gating deficits in schizophrenia.

Authors:  Veena Kumari; Emmanuelle R Peters; Dominic Fannon; Preethi Premkumar; Ingrid Aasen; Michael A Cooke; Anantha P Anilkumar; Elizabeth Kuipers
Journal:  Schizophr Res       Date:  2008-02-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.